Anne‐Marie Buunk

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs

J. Brouwer, Marga Nijenhuis, Bianca Soree et al. · European Journal of Human Genetics · 2021 · 112 citations · Full text

Dutch Pharmacogenetics, Medicine, Pharmacogenomics +6

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)

Maja Matić, Marga Nijenhuis, Bianca Soree et al. · European Journal of Human Genetics · 2021 · 50 citations · Full text

Dutch Pharmacogenetics, Gene–drug Interaction, Pharmacology +6

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs

Lisanne E. N. Manson, Marga Nijenhuis, Bianca Soree et al. · European Journal of Human Genetics · 2024 · 13 citations · Full text

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants

Lianne Beunk, Marga Nijenhuis, Bianca Soree et al. · European Journal of Human Genetics · 2024 · 12 citations · Full text